|
【结 构 式】 
|
【分子编号】36512 【品名】2-(diethoxyphosphoryl)acetic acid 【CA登记号】3095-95-2 |
【 分 子 式 】C6H13O5P 【 分 子 量 】196.139982 【元素组成】C 36.74% H 6.68% O 40.79% P 15.79% |
合成路线1
该中间体在本合成路线中的序号：(II)The esterification of myricerone (I) with 2-(diethoxyphosphoryl)acetic acid (II) by means of CDI gives the corresponding ester (III), which is condensed with the benzaldehyde (IV) by means of DBU and LiCl in DMF yielding the expected condensation product (V). Finally, this compound is hydrolyzed with LiOH in aqueous DME, and treated with aqueous NaOH to obtain the target sodium salt. The intermediate benzaldehyde (IV) has been obtained as follows: The reduction of 5-hydroxy-2-nitrobenzaldehyde (VI) with TiCl3 gives 2-amino-5-hydroxybenzaldehyde (VII), which is then condensed with maleic acid monomethyl ester monochloride (VIII).
| 【1】 Konoike, T.; et al.; Practical large-scala synthesis of endothelin receptor antagonist S-0139. Org Process Res Dev 1999, 3, 5, 347. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 36511 | (6aR,6bR,12aR)-6a-(hydroxymethyl)-2,2,6b,9,9,12a-hexamethyl-10-oxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-4a(2H)-picenecarboxylic acid | C30H46O4 | 详情 | 详情 | |
| (II) | 36512 | 2-(diethoxyphosphoryl)acetic acid | 3095-95-2 | C6H13O5P | 详情 | 详情 |
| (III) | 36513 | (6aR,6bR,12aR)-6a-([[2-(diethoxyphosphoryl)acetyl]oxy]methyl)-2,2,6b,9,9,12a-hexamethyl-10-oxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-4a(2H)-picenecarboxylic acid | C36H57O8P | 详情 | 详情 | |
| (IV) | 36514 | methyl (E)-4-(2-formyl-4-hydroxyanilino)-4-oxo-2-butenoate | C12H11NO5 | 详情 | 详情 | |
| (V) | 36515 | (6aR,6bR,12aR)-6a-([[(E)-3-(5-hydroxy-2-[[(E)-4-methoxy-4-oxo-2-butenoyl]amino]phenyl)-2-propenoyl]oxy]methyl)-2,2,6b,9,9,12a-hexamethyl-10-oxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-4a(2H)-picenecarboxylic acid | C44H57NO9 | 详情 | 详情 | |
| (VI) | 14942 | 5-hydroxy-2-nitrobenzaldehyde | 42454-06-8 | C7H5NO4 | 详情 | 详情 |
| (VII) | 36516 | 2-amino-5-hydroxybenzaldehyde | C7H7NO2 | 详情 | 详情 | |
| (VIII) | 36517 | methyl (E)-4-chloro-4-oxo-2-butenoate | C5H5ClO3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(II)The esterification of myricerone ethyleneketal (IX) with 2-(diethoxyphosphoryl)acetic acid (II) by means of CDI gives the corresponding ester (X), which is condensed with the benzaldehyde (IV) by means of DBU and LiCl in DMF yielding the expected condensation product (XI). The hydrolysis of (XI) with LiOH in aqueous DME affords the free acid (XII), which is treated with HCl in THF/water to eliminate the ketal protecting group providing the target compound as free acid (XII). Finally, this compound is treated with aqueous NaOH to obtain the target sodium salt.
| 【1】 Konoike, T.; et al.; Practical large-scala synthesis of endothelin receptor antagonist S-0139. Org Process Res Dev 1999, 3, 5, 347. |
合成路线3
该中间体在本合成路线中的序号：(IV)Acylation of 6-amino-4-(3-chloro-4-fluorophenylamino)-7-[tetrahydrofuran-3(S)-yloxy]quinazoline (I) with the acid chloride generated from bromocrotonic acid (II) and oxalyl chloride leads to the bromocrotonamide (III), which is finally submitted to bromide displacement with dimethylamine (1). Scheme1.
In an alternative method, aminoquinazoline (I) is acylated with diethylphosphonoacetic acid (IV) by means of carbonyldiimidazole in THF to give the phosphonoacetamide (V), which is finally condensed with (dimethylamino)acetaldehyde diethyl acetal (VI) under basic conditions (2). Scheme 1.
| 【1】 Himmelsbach, F., Langkopf, E., Solca, F., Jung, B., Baum, A., Blech, S. (Boehringer Ingelheim Pharma GmbH & Co., KG). Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof. DE 10063435, EP 1345910, JP 2004516283, US 2002173509, US 2006100223, US 7019012, WO 0250043. |
| 【2】 Soyka, R., Rall, W., Kulinna, C., Sieger, P., Schnaubelt, J. (Boehringer Ingelheim Pharma GmbH & Co., KG). Process for preparing amino crotonyl compounds. DE 10349113, EP 1678165, JP 2007510624, US 2005085495, WO 2005037824. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 65710 | N4-(3-Chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine | 314771-76-1 | C18H16ClFN4O2 | 详情 | 详情 |
| (II) | 50563 | (E)-4-bromo-2-butenoic acid | 13991-36-1 | C4H5BrO2 | 详情 | 详情 |
| (III) | 65711 | C22H19BrClFN4O3 | 详情 | 详情 | ||
| (IV) | 36512 | 2-(diethoxyphosphoryl)acetic acid | 3095-95-2 | C6H13O5P | 详情 | 详情 |
| (V) | 65712 | C24H27ClFN4O6 | 详情 | 详情 | ||
| (VI) | 65713 | 2,2-Diethoxy-N,N-dimethylethylamine; (Dimethylamino)acetaldehyde diethyl acetal | 3616-56-6 | C8H19NO2 | 详情 | 详情 |